share_log

Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horvath Susan

Panbela Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Horvath Susan

Panbela Therapeutics | 4：持股變動聲明-高管 Horvath Susan
美股SEC公告 ·  10/03 16:32

Moomoo AI 已提取核心訊息

Susan Horvath, the Vice President of Finance & CFO of Panbela Therapeutics, Inc. [PBLA], has been reported to engage in a financial transaction involving the company's stock. The transaction took place on October 1, 2024. However, the details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, have not been disclosed or are not available at this time.
Susan Horvath, the Vice President of Finance & CFO of Panbela Therapeutics, Inc. [PBLA], has been reported to engage in a financial transaction involving the company's stock. The transaction took place on October 1, 2024. However, the details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, have not been disclosed or are not available at this time.
Panbela Therapeutics, Inc. [PBLA]的財務副總裁兼財務總監Susan Horvath被報告參與了一項涉及公司股票的金融交易。該交易發生在2024年10月1日。然而，該交易的細節，包括操作類型、狀態、股票數量、股票性質、交易價格和交易後持股，目前尚未披露或不可用。
Panbela Therapeutics, Inc. [PBLA]的財務副總裁兼財務總監Susan Horvath被報告參與了一項涉及公司股票的金融交易。該交易發生在2024年10月1日。然而，該交易的細節，包括操作類型、狀態、股票數量、股票性質、交易價格和交易後持股，目前尚未披露或不可用。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間